Protective effects of pentoxifylline in retinal ischemia/reperfusion injury

Ophthalmologica

Volumn 217, Issue 5, 2003, Pages 337-341

  Demir, Tamer ^a,b   Ulas, Fatih ^a   Ozercan, Ibrahim ^a   Ilhan, Nevin ^a   Celiker, Ulku ^a   Yasar, M Akif ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Pentoxifylline; Retinal ischemia and reperfusion

Indexed keywords

MALONALDEHYDE; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; GUINEA PIG; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; LIPID PEROXIDATION; MALE; NONHUMAN; PROPHYLAXIS; REPERFUSION INJURY; RETINA ISCHEMIA; STATISTICAL SIGNIFICANCE; THICKNESS;

ANIMALS; FREE RADICAL SCAVENGERS; GUINEA PIGS; ISCHEMIA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; REPERFUSION INJURY; RETINAL VESSELS;

EID: 0042161567     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071348     Document Type: Article

References (36)

1. Parks DA, Granger DN, Bulkley GB, Shah AK: Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine. Gastroenterology 1985;82:9-15.
2. 2+) by free radical scavengers in the rat retina. Ophthalmic Res 1993;25:1-9.
3. Szabo ME, Droy-Lefaix MT, Doly M, Carre C, Braquet P: Ischemia and reperfusion induced histologic changes in the rat retina. Invest Ophthalmol Vis Sci 1991;32:1471-1478.
4. Ventura ACS, Böhnke M: Pentoxifylline influences the autocrine function of organ cultured donor corneas and enhances endothelial cell survival. Br J Ophthalmol 2001;85:1110-1114.
5. D'Hellencourt CL, Diaw L, Cornillet P, Guenounou M: Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol 1996;18:739-748.
6. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliot J, Mosmann T, Wegmann TG: IL-10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 1995;154:4261-4268.
7. Zabel P, Schoenharting MM, Schade FU: Effects of pentoxifylline in endotoxinemia in human volunteers. Prog Clin Biol Res 1991;367:207-213.
8. Arias-Diaz J, Vara E, Torres-Melero J, Garcia C, Hernandez J, Balibrea JL: Local production of oxygen free radicals and nitric oxide in rat diaphragm during sepsis: Effects of pentoxifylline and somatostatin. Eur J Surg 1997;163:619-625.
9. Hughes WF: Quantitation of ischemic damage in the rat retina. Exp Eye Res 1991;53:573-582.
10. Alagoz G, Celiker U, Ilhan N, Yekeler H, Demir T, Celiker H: L-Carnitine in experimental retinal ischemia-reperfusion injury. Ophthalmologica 2002;216:144-150.
11. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
12. Sonkin PL, Sinclair SH, Hatchell DL: The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity. Am J Ophthalmol 1993;115:775-780.
13. Sonkin PL, Kelly LW, Sinclair SH, Hatchell DL: Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Arch Ophthalmol 1993;111:1647-1652.
14. Kamphuis J, Smits P, Thien T: Vascular effects of pentoxifylline in humans. J Cardiovasc Pharmacol 1994;26:648-654.
15. Nelson JL, Alexander JW, Mao JX, Vohs T, Ogle CK: Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis. Crit Care Med 1999;27:13-19.
16. Incandela L, Cesarone MR, Belcaro G, Steigerwalt R, De Sanctis MT, Nicolaides AN, Griffin M, Geroulakos G, Ramaswami G: Treatment of vascular retinal disease with pentoxifylline: A controlled, randomized trial. Angiology 2002;53:31-34.
17. De Sanctis MT, Cesarone MR, Belcaro G, Incandela L, Steigerwalt R, Nicolaides AN, Griffin M, Geroulakos G: Treatment of retinal vein thrombosis with pentoxifylline: A controlled, randomized trial. Angiology 2002;53:35-38.
18. Koo DJ, Yoo P, Cioffi WG, Bland KI, Chaudry IH, Wang P: Mechanism of beneficial effects of pentoxifylline during sepsis: Maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J Surg Res 2000;91:70-76.
19. Bath PM, Bath FJ, Asplund K: Pentoxifylline and pentifylline for acute ischemic stroke. Cochrane Database Syst Rev 2000;2:CD000162.
20. Ishizaka A, Wu ZH, Stephens KE, Harada H, Hogue RS, O'Hanley PT, Raffin TA: Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am Rev Respir Dis 1988;138:376-384.
21. Rieneck K, Diamant M, Haahr PM, Schonharting M, Bendtzen K: In vitro immunomodulatory effects of pentoxifylline. Immunol Lett 1993;37:131-138.
22. Werns SW, Shea MJ, Lucchesi BR: Free radicals in ischemic myocardial injury. J Free Radic Biol Med 1985;1:103-110.
23. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW: Hypoxia increases production of interleukine-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991;3:189-194.
24. Balibrea JL, Arias-Diaz J, Garcia C, Vara E: Effect of pentoxifylline and somatostatin on tumor necrosis factor production by human pulmonary macrophages. Circ Shock 1994;43:51-56.
25. Smedley LA, Tonessen MG, Sandhaus RA, Haslett C, Guthrie LA, Johnston RB, Henson PM, Worthen GS: Neutrophil-mediated injury to endothelial cells: Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986;77:1233-1243.
26. Dauber IM, Lesnefsky EJ, Ashmore RC, Martel DM, Sheridan FM, Weil JV, Horwitz LD: Coronary vascular injury due to ischemia-reperfusion is reduced by pentoxifylline. J Pharmacol Exp Ther 1992;260:1250-1256.
27. Ophir A, Berenshtein E, Kitrossky N, Averbukh E: Protection of the transiently ischemic cat retina by zinc-desferrioxamine. Invest Ophthalmol Vis Sci 1994;35:1212-1222.
28. Cadenas E: Biochemistry of oxygen toxicity. Annu Rev Biochem 1989;58:79-110.
29. Hayreh SS, Podhajksy P: Ocular neovascularisation with retinal vascular occlusion. Arch Ophthalmol 1982;100:1585-1589.
30. Bessler H, Gilgal R, Djadetti M, Zahavi I: Effect of pentoxifylline on the phagocytic activity, cAMP levels and superoxide anion production by monocytes and polymorphonuclear cells. J Leukocyte Biol 1986;40:747-754.
31. Tsai LY, Lee KT, Tsai SM, Lee SC, Yu HS: Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice. Clin Chim Acta 1993;215:41-50.
32. Faberowski N, Stefannsson E, Davidson RC: Local hypothermia protects the retina from ischemia. Invest Ophthalmol Vis Sci 1989;30:2309-2313.
33. Briggs RT, Robinson JM, Arnovsky ML, Karnovsky MJ: Superoxide production by polymorphonuclear leukocytes. Histochemistry 1986;84:371-378.
34. Weiss SJ, Peppin GJ: Collagenolytic metalloenzymes of the human neutrophil: Characteristics, regulation and potential function in vivo. Biochem Pharmacol 1986;35:3189-3197.
35. Mandell GL: Cytokines, phagocytes and pentoxifylline. J Cardiovasc Pharmacol 1995;25(suppl 2):20-22.
36. Hinder RA, Stein HJ: Oxygen derived free radicals. Arch Surg 1991;126:104-106.